Read our latest news, and find more about us and our portfolio companies.
Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial
Comment from Kai Beckmann, member, executive board, Merck KGaA
Appoints Amit Munshi as Chair, deeply experienced industry executive, CEO of Arena Pharmaceuticals
To Lead XTX201 (Tumor-Selective IL-2) and XTX101 (Tumor-Selective aCTLA-4) into the Clinic while Xilio Continues to Advance its Tumor-Selective Cytokine Pipeline
ENDEAVORTM (AKL-T01) is now available for use by children with attention deficit hyperactivity disorder (ADHD) and their families
First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman
Spinout Announces Investment From M Ventures, the Strategic, Corporate Venture Capital Arm of Merck KGaA, Darmstadt, Germany, to Deliver Scalable, Energy-Efficient Quantum Computing Systems
To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing
Artios Pharma Limited today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development
iOnctura SA announces the addition of new members to its Clinical Advisory Board (CAB)
Circuit elements that store information in their electrical resistances enable a brain-like form of computing, storing and processing information in the same place